453 related articles for article (PubMed ID: 24297641)
1. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report.
Bogaczewicz J; Sobów T; Bogaczewicz A; Robak E; Bienkowski P; Sysa-Jedrzejowska A; Wozniacka A
Lupus; 2014 Feb; 23(2):188-93. PubMed ID: 24297641
[TBL] [Abstract][Full Text] [Related]
2. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric systemic lupus erythematosus presenting as bipolar I disorder with catatonic features.
Alao AO; Chlebowski S; Chung C
Psychosomatics; 2009; 50(5):543-7. PubMed ID: 19855042
[TBL] [Abstract][Full Text] [Related]
4. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita A; Yoshimura R; Okamoto T; Umene-Nakano W; Ueda N; Hori H; Katsuki A; Saito K; Tanaka Y; Nakamura J
World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
[TBL] [Abstract][Full Text] [Related]
5. A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.
Costedoat-Chalumeau N; Dunogué B; Leroux G; Morel N; Jallouli M; Le Guern V; Piette JC; Brézin AP; Melles RB; Marmor MF
Clin Rev Allergy Immunol; 2015 Dec; 49(3):317-26. PubMed ID: 25672591
[TBL] [Abstract][Full Text] [Related]
6. [Alpha-interferon and mental disorders].
Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
8. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
[No Abstract] [Full Text] [Related]
9. Psychiatric symptoms induced by hydroxychloroquine.
Gonzalez-Nieto JA; Costa-Juan E
Lupus; 2015 Mar; 24(3):339-40. PubMed ID: 25378239
[No Abstract] [Full Text] [Related]
10. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
Polanski JF; Tanaka EA; Barros H; Chuchene AG; Miguel PTG; Skare TL
Laryngoscope; 2021 Mar; 131(3):E957-E960. PubMed ID: 32603516
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
Parke AL
J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
[TBL] [Abstract][Full Text] [Related]
13. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
[TBL] [Abstract][Full Text] [Related]
14. [Current view on chloroquine derivative treatment from rheumatologist perspective and possible ocular side effects].
Pawlak-Buś K; Gaca-Wysocka M; Grzybowski A; Leszczyński P
Pol Merkur Lekarski; 2016 Mar; 40(237):202-6. PubMed ID: 27088206
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
Parke A; West B
J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
[TBL] [Abstract][Full Text] [Related]
16. Keratopathy with low dose chloroquine therapy.
Cullen AP; Chou BR
J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine psychosis masquerading as PCP: a case report.
Collins GB; McAllister MS
J Psychoactive Drugs; 2008 Jun; 40(2):211-4. PubMed ID: 18720672
[TBL] [Abstract][Full Text] [Related]
18. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD
Lupus; 1998; 7(2):80-5. PubMed ID: 9541091
[TBL] [Abstract][Full Text] [Related]
19. [Neuropsychiatric manifestations in systemic lupus erythematosus].
Alexa ID; Stoica MS; Paraschiv O; Rusu RI
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):322-5. PubMed ID: 17802940
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome following first trimester exposure to chloroquine.
Levy M; Buskila D; Gladman DD; Urowitz MB; Koren G
Am J Perinatol; 1991 May; 8(3):174-8. PubMed ID: 2029276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
